Brut Classic Aerosol Spray Deodorant [Canada]

Click to enlarge

Canada/Ottawa: LZ Corp./K-G Spray-Pak, Inc., a Mississauga, Ontario establishment, recalls an estimated 8,600 cans of Brut Classic Aerosol Spray Deodorant from the Canadian marketplace due to elevated levels of Benzene and consequential risks of Cancers of the Blood and Blood-Forming Tissues, including the Bone Marrow and the Lymphatic System including Leukemia, all serious health and safety hazards requiring immediate medical intervention to minimize pain and suffering as well as prevent life-changing injury.

HCSC: http://ht.ly/iT2L30scnPU

Direct link: https://recalls-rappels.canada.ca/en/alert-recall/brut-classic-aerosol-spray-deodorant-recalled-due-potential-presence-benzene

Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following Aerosol Spray Deodorant products are subject to this recall:

Ombrelle Garnier Dry Mist Spray Sunscreen [Canada]

Enlarge

Canada/Ottawa: Ombrelle Canada, a Toronto, Ontario establishment and a subsidiary of Ombrella Marketing Company of Middletown, Delaware, a division of L’Oréal of Paris, France, recalls all current batch/lots of Ombrelle Garnier Complete Dry Mist Spray Sunscreen, SPF 30 and SPF 60, from the Canadian marketplace due to elevated levels of Benzene and consequential risks of Cancers of the Blood and Blood-Forming Tissues, including the Bone Marrow and the Lymphatic System including Leukemia, all serious health and safety hazards requiring immediate medical intervention to minimize pain and suffering as well as prevent life-changing injury.

HCSC: http://ht.ly/JJlk30rXCuB

Direct link: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76663a-eng.php

Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following Ombrelle Garnier Complete Dry Mist Spray Sunscreen products are subject to this recall:

Pfizer Chantix (Varenicline) Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Pfizer, a Manhattan, New York establishment, recalls certain batch/lots of Chantix Tablets due to the presence of N-nitroso-varenicline contamination and consequential risks of increased carcinogenicity (Cancer), severe illness and/or possible life-changing complications, all serious health and safety hazards/situations requiring immediate medical intervention to minimize suffering and prevent life-changing injury.

FDA: http://ht.ly/sDqw30rRBS6

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pfizer-expands-voluntary-nationwide-recall-include-four-additional-lots-chantixr-varenicline-tablets

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Chantix (Varenicline) Tablets are subject to this recall:

Lupin Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Lupin Pharmaceuticals, Inc., a Baltimore, Maryland establishment, recalls all current batch/lots of Lupin Pharma branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/NuJP30qY97Z

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Granules Pharma Metformin Hydrochloride Recall [US]

Click to enlarge image

US/Silver Spring: Granules Pharmaceuticals, Inc., a Chantilly, Virginia establishment, recalls twelve (12) batch/lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/dXLm30qX5hG

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/granules-pharmaceuticals-inc-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Apotex Metformin Hydrochloride Tablet Recall [Canada]

Click to enlarge image

Canada/Ottawa: Apotex Corp., a Toronto, Ontario establishment, recalls certain batch/lots of Apotex Corp branded Metformin Hydrochloride Extended-Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable Health Canada levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

HCSC: http://ht.ly/RIm630qRn75

Direct link: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73339r-eng.php

Additional information:
The Health Canada (“HCSC) reports the following Metformin medications are subject to this recall:

Lupin Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Lupin Pharmaceuticals, Inc., a Baltimore, Maryland establishment, recalls certain batch/lots of Lupin Pharma branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/GfnZ30qQfdN

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-one-lot-metformin-hydrochloride

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Apotex Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Apotex Corp., a Toronto, Ontario establishment, recalls certain batch/lots of Apotex Corp branded Metformin Hydrochloride Extended-Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/HmUE30qPhSK

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended-release-tablets

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Actavis Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Teva Pharmaceuticals USA, Inc., a Parsippany, New Jersey establishment and subsidiary of Teva Pharmaceutical Industries Ltd. of Petah Tikva, Israel, recalls certain batch/lots of Actavis Pharma, Inc. branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/q9Pu30qOed1

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-pharmaceuticals-usa-inc-initiates-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Time-Cap Labs Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Marksans Pharma Limited, a Verna, Goa, India establishment, recalls certain batch/lots of Time-Cap Labs, Inc. branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/upL630qNRGM

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/marksans-pharma-limited-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended-release

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Amneal Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Amneal Pharmaceuticals LLC, a Bridgewater, New Jersey establishment, recalls all current batch/lots of Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/pU8030qNxkW

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

American Health Ranitidine Tablet Recall [US]

Click to enlarge

US/Silver Spring: American Health Packaging, a Columbus, Ohio establishment, recalls eleven (11) lots of Ranitidine Tablets, USP 150 mg, 100 count Unit Dose Blisters from the American marketplace due to suspected levels of N-Nitrosodimethylamine (“NDMA”), a probable Human Carcinogen, above the allowable limits established by the FDA and consequential risk of Cancer, all serious health hazards.

FDA: http://ht.ly/gFcQ30qnOVO

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-health-packaging-issues-voluntary-nationwide-recall-ranitidine-tablets-usp-150-mg-100-count

Additional information:
The US Food and Drug Administration (“FDA”) reports the following prescription drug products are subject to this recall:

Perrigo branded Ranitidine Recall [US]

US/Silver Spring: Perrigo Company plc, an Allegan, Michigan establishment and a subsidiary of Perrigo of Hogan Place, Dublin, Ireland, recalls all current batch/lots and package sizes of Ranitidine, a drug available OTC and by prescription within the United States, due to a specific Nitrosamine contamination called N-nitrosodimethylamine (“NDMA”), a probable human Carcinogen, a substance that could cause Cancer, all serious health hazards.

FDA: http://ht.ly/Msef30pNfyx

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/perrigo-company-plc-issues-voluntary-worldwide-recall-ranitidine-due-possible-presence-impurity-n

Additional information:
The US Food and Drug Administration (“FDA”) reports the following drug products are subject to this recall:

Teva Pharmaceuticals Valsartan Recall [US]

US/Silver Spring: Teva Pharmaceuticals USA, a Parsippany-Troy Hills, New Jersey establishment, recalls all current batch/lots of Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets due to suspected contamination N-nitroso-diethylamine (“NDEA”) a probable human carcinogen., all serious health and safety hazards.

FDA: http://ht.ly/YzxN30mRMeY

Direct link: https://www.fda.gov/Safety/Recalls/ucm626802.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following drugs are subject to this recall: